Literature DB >> 24463961

Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor.

Sho Ishizawa1, Junko Takahashi-Fujigasaki, Yasushi Kanazawa, Keiichiro Matoba, Daiji Kawanami, Tamotsu Yokota, Takeo Iwamoto, Naoko Tajima, Yoshinobu Manome, Kazunori Utsunomiya.   

Abstract

BACKGROUND: Sphingosine-1-phosphate (S1P) is reportedly involved in the pathogenesis of kidney disease; however, the precise role played by S1P in renal disorders still remains controversial. Rho kinase plays an important role in the development of diabetic nephropathy by inducing glomerular and tubulointerstitial fibrosis. Rho kinase is known to be stimulated by S1P through its specific receptor, S1P2 receptor (S1P2). Hence, we investigated whether S1P-S1P2 signaling plays a role in the epithelial-mesenchymal transition (EMT) through Rho kinase activation in renal tubules.
METHOD: To characterize the distribution of the S1P2, an immunohistochemical examination of the receptor was performed in the kidney of the non-diabetic and diabetic mice. Next, we examined Rho kinase activity as well as E-cadherin and alpha-smooth muscle actin (α-SMA) expression by real-time RT-PCR and western blotting in cultured rat tubular epithelial cells under S1P stimulation with and without a Rho kinase inhibitor and an S1P2 blocker. In addition, the distribution of E-cadherin and α-SMA was examined by immunocytochemistry. RESULT: S1P2 was expressed mainly in the renal tubules; expression was intense in collecting ducts and distal tubules compared to other segments. S1P induced activation of Rho kinase through the S1P2, which changed the distribution of E-cadherin and increased the expression of α-SMA.
CONCLUSION: Rho kinase activation by S1P via S1P2 initiated EMT changes in cultured renal tubular cells. Our results suggest that excessive stimulation of S1P might facilitate renal fibrosis via activation of Rho kinase through S1P2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463961     DOI: 10.1007/s10157-014-0933-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  28 in total

1.  ROCK and Dia have opposing effects on adherens junctions downstream of Rho.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

2.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.

Authors:  Egle Avizienyte; Anne W Wyke; Robert J Jones; Gordon W McLean; M Andrew Westhoff; Valerie G Brunton; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

3.  Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition.

Authors:  Egle Avizienyte; Valerie J Fincham; Valerie G Brunton; Margaret C Frame
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

4.  Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway.

Authors:  David A Tumbarello; Christopher E Turner
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

5.  Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats.

Authors:  A Bischoff; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis.

Authors:  Jennifer L Faulkner; Lisa M Szcykalski; Fredyne Springer; Jeffrey L Barnes
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

7.  The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats.

Authors:  Ganlin Wu; Yafang Tu; Ruhan Jia
Journal:  Biomed Pharmacother       Date:  2009-10-23       Impact factor: 6.529

8.  Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.

Authors:  Hikaru Sugimoto; Gordan Grahovac; Michael Zeisberg; Raghu Kalluri
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

9.  Unbalanced expression of sphingosine 1-phosphate receptors in diabetic nephropathy.

Authors:  Toshiyuki Imasawa; Hiroshi Kitamura; Ryunosuke Ohkawa; Yumiko Satoh; Akiko Miyashita; Yutaka Yatomi
Journal:  Exp Toxicol Pathol       Date:  2009-03-03

Review 10.  Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases.

Authors:  Y Yatomi
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

View more
  14 in total

1.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

Review 2.  Lipid deposition and metaflammation in diabetic kidney disease.

Authors:  Alla Mitrofanova; Antonio M Fontanella; Sandra Merscher; Alessia Fornoni
Journal:  Curr Opin Pharmacol       Date:  2020-11-01       Impact factor: 5.547

3.  Knockout of Sphingosine Kinase 1 Attenuates Renal Fibrosis in Unilateral Ureteral Obstruction Model.

Authors:  Xiwen Zhang; Weili Wang; Xin-Ying Ji; Joseph K Ritter; Ningjun Li
Journal:  Am J Nephrol       Date:  2019-08-15       Impact factor: 3.754

Review 4.  Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.

Authors:  C Hu; L Sun; L Xiao; Y Han; X Fu; X Xiong; X Xu; Y Liu; S Yang; F Liu; Y S Kanwar
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 5.  Sphingolipids and Kidney Disease: Possible Role of Preeclampsia and Intrauterine Growth Restriction (IUGR).

Authors:  Rodrigo Yokota; Benjamin Bhunu; Hiroe Toba; Suttira Intapad
Journal:  Kidney360       Date:  2021-01-07

6.  Loss of Arhgef11 in the Dahl Salt-Sensitive Rat Protects Against Hypertension-Induced Renal Injury.

Authors:  Ashley C Johnson; Wenjie Wu; Esinam M Attipoe; Jennifer M Sasser; Erin B Taylor; Kurt C Showmaker; Patrick B Kyle; Merry L Lindsey; Michael R Garrett
Journal:  Hypertension       Date:  2020-03-09       Impact factor: 10.190

Review 7.  Sphingosine-1-phosphate pathway in renal fibrosis.

Authors:  Xiwen Zhang; Joseph K Ritter; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-04

Review 8.  Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Authors:  Sandra Merscher; Alessia Fornoni
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-30       Impact factor: 5.555

9.  Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.

Authors:  Mohamed H Shahin; Yan Gong; Reginald F Frye; Daniel M Rotroff; Amber L Beitelshees; Rebecca A Baillie; Arlene B Chapman; John G Gums; Stephen T Turner; Eric Boerwinkle; Alison Motsinger-Reif; Oliver Fiehn; Rhonda M Cooper-DeHoff; Xianlin Han; Rima Kaddurah-Daouk; Julie A Johnson
Journal:  J Am Heart Assoc       Date:  2017-12-29       Impact factor: 5.501

Review 10.  Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate.

Authors:  Norishi Ueda
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.